Australia Inhalation & Nasal Spray Generic Drugs Market Size & Outlook
The inhalation & nasal spray generic drugs market in Australia is expected to reach a projected revenue of US$ 538.2 million by 2030. A compound annual growth rate of 7.8% is expected of Australia inhalation & nasal spray generic drugs market from 2025 to 2030.
Revenue, 2024 (US$M)
$343.9
Forecast, 2030 (US$M)
$538.2
CAGR, 2025 - 2030
7.8%
Report Coverage
Australia
Australia inhalation & nasal spray generic drugs market, 2018-2030 (US$M)
Related Markets
Australia inhalation & nasal spray generic drugs market highlights
- The Australia inhalation & nasal spray generic drugs market generated a revenue of USD 343.9 million in 2024 and is expected to reach USD 538.2 million by 2030.
- The Australia market is expected to grow at a CAGR of 7.8% from 2025 to 2030.
- In terms of segment, bronchodilators was the largest revenue generating drug class in 2024.
- Combination Drugs is the most lucrative drug class segment registering the fastest growth during the forecast period.
Inhalation & nasal spray generic drugs market data book summary
| Market revenue in 2024 | USD 343.9 million |
| Market revenue in 2030 | USD 538.2 million |
| Growth rate | 7.8% (CAGR from 2024 to 2030) |
| Largest segment | Bronchodilators |
| Fastest growing segment | Combination Drugs |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Bronchodilators, Combination Drugs, Corticosteroids, Decongestant Sprays, Antihistamines, Other Drug Classes |
| Key market players worldwide | Teva Pharmaceutical Industries Ltd, Cipla Ltd DR, Novartis AG ADR, Hikma Pharmaceuticals PLC, Sun Pharmaceutical Industries, Beximco Pharmaceuticals Ltd DR, Mylan, Akorn, Apotex Inc., Nephron Pharmaceuticals |
Other key industry trends
- In terms of revenue, Australia accounted for 1.1% of the global inhalation & nasal spray generic drugs market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China inhalation & nasal spray generic drugs market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 3,767.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Inhalation & Nasal Spray Generic Drugs Market Scope
Inhalation & nasal spray generic drugs market segmentation & scope
Inhalation & Nasal Spray Generic Drugs Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Australia inhalation & nasal spray generic drugs market size, by drug class, 2018-2030 (US$M)
Australia Inhalation & Nasal Spray Generic Drugs Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
